Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates

Bluebird Bio (BLUE) came out with a quarterly loss of $3.55 per share versus the Zacks Consensus Estimate of a loss of $3.03. This compares to loss of $2.91 per share a year ago. These figures are adjusted for non-recurring items.